AFP and cancer: Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-related death worldwide.1 Many clinical factors are important in the prognosis of patients with HCC, including disease stage, Eastern Cooperative Oncology Group performance status (ECOG PS), histopathology, liver function and serum alpha-fetoprotein (AFP) levels.2–4